-
Long-Term Outcomes with Valbenazine 40 mg/day in Adults with Tardive Dyskinesia
-
Long-term safety and efficacy of apomorphine infusion in Parkinson’s disease (PD) patients with persistent motor fluctuations: results of the 1-year open-label phase of the TOLEDO study
-
Long-term safety and efficacy of rimabotulinumtoxinB in the treatment of adult sialorrhea
-
Long-term treatment of cervical dystonia with abobotulinumtoxinA
-
Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia: Results From an Open-Label Extension Study
-
Long-term Yearly Trends of Feeding Tube Placement in Neurodegenerative Disorders
-
Longitudinal analysis of disease progression in a large PKAN cohort in the Dominican Republic
-
Longitudinal Analysis of the Corticospinal tract microstructure in Parkinson’s Disease Patients
-
Longitudinal analysis of the modified Hoehn and Yahr disease stage in PD-1101, a Phase 1b clinical study of VY-AADC01
-
Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson’s disease
- « Previous Page
- 1
- …
- 117
- 118
- 119
- 120
- 121
- …
- 217
- Next Page »